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ABSTRACT
Objectives To explore the inﬂuence of a guideline-
based computerised decision support system (CDSS)
on general practitioners’ (GPs’) management of
patient cases of chronic heart failure in a pragmatic
clinical situation. We assessed changes in the GPs’
conﬁdence in the diagnosis, their considerations
about investigations and medications and the sup-
port they perceived from using the CDSS.
Study design Five GPs assessed the medical rec-
ords of 48 of their own authentic patient cases using
a guideline-based CDSS accessible on the internet
for the diagnosis and treatment of chronic heart
failure, and completed a questionnaire for each case.
Outcomemeasures Number of cases where theGP
reported a change in conﬁdence in the diagnosis,
where the GP considered further investigations or
changes in medication and the perceived support
marked on a visual analogue scale.
Results The GPs’ conﬁdence in the diagnosis
changed in 25% of the cases, with equal numbers
of increases and decreases in conﬁdence. The GPs
considered further investigations in 31% of the
cases and medication changes in 19%. Fourteen of
the 31 considered investigations and four of the ten
considered changes in medications which were in
agreement with the CDSS’s suggestions. The GPs
tended to consider further investigations more
often in cases when the CDSS found the diagnosis
uncertain. There was a wide range in the values for
perceived support, but it could be described as sub-
stantial in 35% of the cases.
Conclusion Using a guideline-based CDSS for the
GPs’ own patient cases had an impact on the GPs’
conﬁdence in the diagnosis of chronic heart failure
and their considerations about investigations and
medications: they also perceived substantial sup-
port in every third case. Applying aCDSS developed
using evidence-based guidelines for chronic heart
failure in primary care could have a signiﬁcant
inﬂuence on GPs’ disease management.
Keywords: computerised decision support sys-
tems, guideline implementation, primary care
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Introduction
Computerised decision support systems (CDSSs) have
become well-known tools for enhancing evidence-
based decisions in clinical practice. According to
several studies, CDSSs have the potential to inﬂuence
clinicians’ decision-making and to facilitate the im-
plementation of new diseasemanagement strategies in
everyday clinical work, as they integrate individual
patient data with evidence-based recommendations.1–6
Despite large investments in developing and imple-
menting evidence-based clinical practice guidelines,
guidelines are still not used optimally by practitioners.7
Several studies show that they are used more when
they are presented in computerised form, when patient-
speciﬁc advice is given and when they are integrated
with clinical activities.8–11 Evaluation studies are, how-
ever, mostly performed in experimental settings and
rarely use a naturalistic designwith real patients.12 The
results of the studies performed in clinical settings have
varied and only a few have shown improved adherence
to guideline recommendations and better patient
care.13–18 The views of users regarding the functioning
of the CDSS, its relevance and its helpfulness in
decision making are of importance to the success of
guideline-based CDSSs.19 Studies focusing on how a
CDSS inﬂuences clinicians’ reasoning in authentic
patient cases are scarce.
Chronic heart failure (CHF) is a common condition,
especially among the elderly, and is associated with
highmortality andmorbidity. The burden on the health
care system resulting from the management of CHF is
rising in parallel with the increasing proportion of
elderly persons in the population. In Sweden, CHF is
mostly managed at primary healthcare (PHC) centres.
Its management is often complex and both over-
diagnosis and under-diagnosis are common.20 The
guidelines for treatment of CHF have been revised in
the past few years but GPs’ adherence to the guidelines
is insuﬃcient.21 CHF is therefore an important ﬁeld
for studies about the inﬂuence of a guideline-based
CDSS on GPs’ clinical performance.
The aim of this study was to explore the inﬂuence of
a CDSS on GPs’ conﬁdence in the diagnosis and their
considerations about investigations and medications
in their own patient cases of CHF. A secondary aim
was to explore to what extent the GPs perceived using
the CDSS as supportive.
Material and methods
Setting and participants
The study was performed in February 2005 at a PHC
centre in a suburban area of Stockholm with
approximately 6500 inhabitants. Six female GPs worked
at the PHC centre, including one of the authors (ETP).
The remaining ﬁve participated in the study. They had
between three and 27 years of clinical experience in
PHC. None of the GPs had indicated having any
speciﬁc interest in the management of CHF.
The PHC centre had used an electronic patient
record (EPR) as the sole medical record since 1994.
The present EPR was introduced in 1999, and included
patient records only from that time and forward.
Notes on diagnoses followed the International Classi-
ﬁcation of Diseases (ICD-10). The recording of a
diagnosis in each encounter note was recommended
but notmandatory. None of theGPs hadmore than an
average interest in computers either privately or
professionally. Before this study, no CDSSs had been
used on a consistent basis at the PHC centre.
Selection of CHF cases
We identiﬁed the medical records of all patients who
had had the diagnosis ‘heart failure’ (ICD-code: I50-)
recorded during the last ﬁve years by searching the
database of the EPR system. Thereafter we selected those
who were still being treated for their CHF problems at
the PHC centre (that is, excluding the patients who
had died orwhoseCHFproblemswere beingmanaged
elsewhere). Forty-eight patients fulﬁlled those criteria.
For each case we then identiﬁed the encounters in the
medical records where the diagnosis or symptoms
associated with CHF were noted and selected one of
the latest of those encounters. We allocated each case
exclusively to the GP who had seen the patient at that
encounter.
The CDSS
The CDSS used, Evibase1, was a web-based appli-
cation written in Swedish and freely accessible on the
internet.22 It comprised four separate modules, all
with the same basic structure.23 In this study we used
the diagnostic and the treatment modules for the
management of CHF, based on three evidence-based
clinical guidelines published earlier in paper form.24–26
The two modules could be used independently of one
another. Both contained a form with check boxes for
patient data that the user had to ﬁll in before triggering
the program. The result sheet appeared on screen
immediately and was printable on demand. It always
contained a list of all the entered patient data for a
second check and it was possible to go back and make
changes. After closing the window or starting a fresh
form, no data from the previous case were stored.
In the diagnostic module, the form for patient data
contained boxes with symptoms and signs, examination
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results and aetiological factors (see Figure 1). The
result sheet presented short, concise statements
structured in paragraphs. The ﬁrst paragraph stated
the presence or absence of symptoms, objective evi-
dence (that is, impaired cardiac function on the
echocardiogram) and aetiological factors supporting
the diagnosis of CHF in the present case. The second
paragraph gave a suggestion on the probability of CHF
with ﬁve alternatives:
1 ‘CHF is present’ occurred when both symptoms
and objective evidence were present
2 ‘asymptomatic dysfunction’ occurred when objec-
tive evidence was present without any symptoms
3 ‘suspect CHF’ occurred when symptoms were pre-
sent but echocardiography was not performed
4 ‘CHF is not present’ occurred when the result of the
echocardiogram was normal
5 ‘not possible to calculate’ occurredwhen therewere
no symptoms and echocardiography was not per-
formed.
The third paragraph contained comments on the
entered patient data, their impact on the probability
of CHF and suggestions for further investigations.
Since the principal diagnostic investigation is echo-
cardiography, if the box ‘ejection fractionmissing’was
marked in the form, the result sheet always included a
suggestion to perform echocardiography. Taking a
blood test, brain natriuretic peptide (BNP), could
also be suggested as a complementary investigation.
In addition to echocardiography and BNP, there could
be the suggestion of an exercise test as a further
investigation for breathlessness.
In the treatment module there was an assumption
that CHF was present. It provided suggestions on
suitable drugs for additional treatment. Its form for
patient data comprised checklists for:
. functional classiﬁcation according to the New York
Heart Association’s scale (NYHA I–IV)
. related medical conditions
. medications
. drugs not tolerated by the patient.
The result sheet gave suggestions on groups of drugs
suitable for adding to those already used. Further-
more, there was a list of advantages and disadvantages
of all the theoretically usable drugs in the present case,
listed in order of importance. The user could repeat
Figure 1 The form for patient data in the diagnostic module of the CDSS (Evibase1) (translated to English)
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the inquiry for additional suggestions on the same case
up to a maximum of ﬁve repetitions.
Thus, in addition to the tangible suggestions on
how to proceed in the present case, the result sheet for
both modules also provided information on the most
important rules underlying the calculation of each
suggestion. In this way the CDSS also functioned
simultaneously as an educational tool.
Training and performance
The GPs attended a demonstration of the CDSS pro-
gram lasting one-and-a-half hours. They were there-
after asked to carry out an assessment of the selected
cases using both the diagnostic and treatment modules
of the CDSS (9–11 cases per GP). After having run a
test case together with the study instructor, who was
subsequently available for technical support, the GPs
worked alone in their oﬃces. The GPs were instructed
to perform as if the selected encounter were taking
place now and for every case to ﬁll in a questionnaire
directly after using each module of the CDSS. There
were ﬁve paragraphs in the questionnaire regarding:
1 whether theGPwould consider further investigations
(with the options: ECG, exercise test, echocardi-
ography, S-BNP, chest X-ray, spirometry or other
speciﬁed investigation)
2 whether her conﬁdence in the diagnosis increased,
decreased or was unchanged
3 whether she would consider some changes in
medications, and if so what kind
4 the overall support from the CDSS perceived by the
GP in the present case (marked on a 100mm visual
analogue scale (VAS), where 0mmwas marked ‘no
support at all’ and 100 mm was marked ‘the maxi-
mum support I can imagine’)
5 the GP’s comments on the assessment of the present
case.
The GPs were also asked to collect all the print-outs of
the result sheets from the CDSS.
Ethical approval
This study was approved by the Regional Ethical
Review Board in Stockholm.
Results
The diagnostic module
The mean age of the patients was 81 years and 60% of
themweremen. Symptoms of CHFwere presentmore
often than clinical signs (in 65% and 42% of the cases,
respectively; see Table 1). The echocardiogram showed
an impaired heart function in 42% of the cases
(‘impaired left ventricular ejection fraction (LVEF)’
or ‘diastolic dysfunction’). No echocardiogram result
was found in 31% of the cases. The CDSS’s diagnostic
suggestion was ‘CHF is not present’ in 27% of the
cases. The suggestions on further investigations in-
cluded echocardiography in 31% and a supplementary
BNP test in 17%.
The GPs’ responses showed that their conﬁdence in
the diagnosis was inﬂuenced by the CDSS in 25% of
the cases,with equal numbers of increased anddecreased
conﬁdence (see Table 1). The GPs considered further
investigations in 15 cases (31 investigations in total of
which 14 were echocardiography).
The treatment module
The patient data contained an NYHA classiﬁcation in
71% of the cases (see Table 2). Most of the patients
(52%)were prescribed between one and three drugs of
the type used for CHF. Diuretics were most common
(85%), followed by betablockers (58%) and ACE inhib-
itors (44%). The most common related medical con-
ditions were coronary heart disease and ﬂuid retention.
ACE inhibitors were the additional medication most
frequently suggested by the CDSS (23%), and the GPs
considered making changes in medications in 19% of
the cases. The change most frequently considered was
addition of ACE inhibitors (in ﬁve cases). In 42% of
the cases the CDSS could not ﬁnd any suitable add-
itional medication at all.
The perceived support
The mean rank value for the support perceived by the
GPs was 15 mm (range 0–81 mm). In six cases the
perceived support was marked as zero (by two GPs).
The individual values for four of the GPs fell into two
intervals with a gap between, one below 40 mm and
the other 40 mm and above (see Figure 2). Therefore,
we regarded a value equal to or above 40 mm as
representing substantial support. According to this
interpretation the perceived support was substantial
in 17 (35%) of the cases, and there was only one GP
who had no value in this range. We could not see any
association between years of clinical experience and
perceived support, except that the GP with the shortest
clinical experience seemed to perceive generally higher
support than the others.
The GPs’ considerations versus the
CDSS’s suggestions
We grouped the GPs’ considerations about investi-
gations according to the CDSS’s diagnostic sugges-
tions (see Table 3). When the suggestion was ‘suspect
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CHF’ or ‘not possible to calculate’, the GPs considered
investigations in 67% of the cases, whereas they did so
in 23% of the cases when the suggestion was ‘CHF not
present’ and in 14% and 15%, respectively in the
remaining two groups. Of the 31 investigations con-
sidered by the GPs, 14 were in agreement with the
CDSS’s suggestions. The GPs considered ten of 15 sug-
gested echocardiographies and two of eight S-BNPs.
In addition, the GPs also considered 17 investigations
not suggested by the CDSS (four echocardiographies,
Table 1 Results from the diagnostic module of the CDSS including patient data recorded in
the forms, the CDSS’s suggestions on the result sheets, and the GPs’ responses in the
questionnaire, given as number of cases (n) and (%) of all cases (n=48)
Patient data n %
CHF symptoms1 None 17 35
1–3 symptoms 31 65
Clinical signs present at the visit2 None 28 58
At least one sign 20 42
Result of the echocardiogram a) Impaired LVEF3 18 38
b) Diastolic dysfunction 2 4
c) Normal echocardiogram 13 27
d) No result found in the
records
15 31
The CDSS’s suggestion
Suggestions on the diagnosis CHF is present 13 27
Asymptomatic dysfunction 7 15
Suspect CHF 12 25
CHF is not present 13 27
Not possible to calculate4 3 6
Suggestions on further
investigations
No further investigations
1–3 further investigations
27
21
56
44
Kind of investigations:5
Echocardiography 15 31
BNP6 8 17
Exercise test7 14 29
The GPs’ responses
Changes in the GPs’ conﬁdence
in the diagnosis
No change
Less conﬁdent
36
6
75
12.5
More conﬁdent 6 12.5
The GPs’ considerations on
further investigations
No investigation
1–4 investigations
33
15
69
31
Kind of investigations5:
Echocardiography 14 29
ECG 4 8
Chest X-ray 6 13
BNP 5 10
Exercise test 2 4
1 Fatigue, breathlessness, dyspnoea or cough at night; 2 Tachycardia, pulmonary crepitation, peripheral oedema; 3 LVEF (Left
Ventricular Ejection Fraction) was regarded as ‘normal’ when >50%; 4 This answer occurred when the GP marked ‘no symptoms’
and ‘ejection fraction missing’ in the form; 5 There could be several investigations suggested and/or considered in the same case;
6 BNP was suggested as a complement to echocardiography; 7Exercise test was suggested when breathlessness was recorded as a
symptom by the GP and the CDSS’s conclusion on the diagnosis was ‘no CHF’ or ‘suspect CHF’
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Table 2 Results from the treatment module of the CDSS including patient data recorded in
the forms, the CDSS’s suggestions on the result sheets and the GPs’ responses in the
questionnaire, given as number of cases (n) and (%) of all cases (n=48)
Patient data n %
Classiﬁcation of function according to NYHA (I–IV) NYHA I 10 21
NYHA II 18 38
NYHA III 5 10
NYHA IV 1 2
Not recorded 13 27
Module not used 1 2
Medications
Number of CHF drugs recorded per patient (median=3) 0 4 8
1–3 25 52
4–6 18 38
Module not used 1 2
Drugs recorded (one or more per patient) Diuretics 41 85
Betablockers 28 58
ACE inhibitors1 21 44
ARB2 4 8
Other 4 8
Related medical conditions (one or more per patient) Coronary heart disease 25 52
Fluid retention 15 31
Asthma/COPD3 9 19
Arrhythmia 6 13
Renal insuﬃciency 6 13
Aortic or mitral stenosis 3 6
Hypotonia 3 6
The CDSS’s suggestions
The CDSS’s suggestions on additional medications ACE-inhibitors 11 23
Cardiac glycosides 6 13
Betablockers 4 8
Potassium-sparing diuretics 4 8
Loop diuretics 2 4
Cannot ﬁnd any 20 42
Module not used 1 2
The GPs’ responses
The GPs’ considerations on change in medications
Number of changes No change 39 81
One change 8 17
Two changes 1 2
Kind of changes:
Add ACE inhibitor 5
Add cardiac glycosides 1
Withdraw a drug 2
Change of dosage 2
1 ACE = Angiotensin-converting enzyme; 2 ARB = Angiotensin II receptor antagonists; 3 COPD = Chronic obstructive pulmonary
disease
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three S-BNPs, four ECGs and six chest X-rays). There
was agreement between the GPs’ considerations about
changes in medications and the CDSS’ suggestions in
four of the ten considered changes.
The GPs’ comments
The GPs wrote comments on a total of 29 cases. We
could distinguish two main categories: one was deal-
ing with the CDSS itself and one with its use in the
clinical situation. Among the comments on the CDSS
itself, three concerned the fact that the check boxes
for ECG in the diagnostic module did not cover all
possible pathological variations. Two comments con-
cerned the fact that the program did not accept a certain
drug combination that was prescribed in line with
existing local routines. The GP had towithdraw one of
the drugs in order to proceed. In one of those cases the
GP chose to quit the treatmentmodule instead (‘module
not used’ in Table 2). Two comments described the
program as suggesting treatment which had already
been input as existingmedication for the patient. That
happened if the GP asked for more suggestions when
Figure 2 Distribution of the marks for perceived overall support reported by the GPs on a 100mm visual
analogue scale. The smallest dots represent onemark, themedium dots twomarks and the largest dots three
marks each
Table 3 Changes in the GPs’ conﬁdence in the diagnosis and the GPs’ considerations
regarding further tests in relation to the CDSS’s diagnostic suggestions (n=48)
The CDSS’s suggestions on the
diagnosis
Changes in the GPs’
conﬁdence in the diagnosis
Proportion of cases where
the GP considered further
investigations in each group
More
conﬁdent
Less conﬁdent
n n n %
‘CHF is present’ (n=13) 1 1 2 of 13 15
‘Asymptomatic
dysfunction’
(n=7) 1 0 1 of 7 14
‘Suspect CHF’ (n=12) 3 2 8 of 12 67
‘CHF not present’ (n=13) 1 3 3 of 13 23
‘Not possible to
calculate’
(n=3) 0 0 2 of 3 67
All cases (n=48) 6 6 16 of 48 33
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the program had replied in the previous step that there
were no suggestions.
Among the comments dealing with the clinical situ-
ation, eight described circumstances overshadowing
a potential CHF, so the GP did not feel justiﬁed in
considering the CDSSs’ suggestions (patients who had
died since the last visit, had other severe conditions or
were very old and without symptoms). In seven cases,
the GP intended to await the results from the inves-
tigations beforemaking any decisions onmedications.
In four cases there was an assenting comment to the
program’s suggestions (for example, ‘Very appropri-
ate in this case to perform a new echocardiography
now’). Two commentsmentioned that the patient also
visited a cardiologist and one that the patient would
not accept more drugs.
Discussion
Using a guideline-based CDSS for the GPs’ own patient
cases inﬂuenced the GPs’ conﬁdence in the diagnosis
of CHF, their considerations about investigations and
their considerations aboutmedications.TheGPs’ overall
perception of support could be regarded as substantial
in more than every third case.
The diagnostic module
The ﬁnding that the GPs’ conﬁdence in the diagnosis
changed in every fourth case after using the CDSS is in
line with other studies assessing clinicians’ conﬁdence
in their responses to clinical questions before and after
using computerised evidence systems.27,28 In our study
the GPs considered further investigations in 67% of
the 15 cases where the diagnosis was uncertain (‘suspect
CHF’ and ‘not possible to calculate’). This proportion
was considerably lower (15%) in the cases where the
CDSS’s suggestions included a conﬁrmed diagnosis
and no further investigations (‘CHF is present’ and
‘asymptomatic dysfunction’). This could reﬂect the
CDSS’s inﬂuence on the GPs’ considerations. Regard-
ing the GPs’ adherence to the CDSS’s suggestions in
each case, they accepted fewer than every second sug-
gestion but considered almost as many others. One
reason for that could be that the CDSS did not take
into account the date of the previously performed
investigations, while the GPs probably did.
The treatment module
The proportion of cases where the GPs considered a
change in medication was lower in our study than
ﬁndings reported by Subramanian showing adherence
to treatment suggestions of a CDSS in 30%of the cases
with a previously conﬁrmed diagnosis of CHF.17 The
reason for this could be that the CDSS in our study
presented suggestions on additional medications when-
ever it was possible to ﬁnd one that was suitable, as the
treatment module worked on the presumption of an
insuﬃciently treated CHF. The GPs, however, might
have found that additional medication was not justi-
ﬁed in the situation or might have preferred to await
the results from the considered investigations. Many
of the GPs’ comments described this discrepancy and
we therefore think that itwouldhave beenmore eﬃcient
to use the two modules on separate occasions.
There were 20 cases in our study where the CDSS
did not ﬁnd any suitable medication to add, which
could indicate that those patients were already being
optimally treated or the caseswere too complicated for
the program. Further, another perceived shortcoming
was that the CDSS could not give advice on the
question of which was preferable, adjusting the dosage
of drugs already prescribed or prescribing an add-
itional drug, as this decision often depends on how the
patient tolerates the drugs. This implies that decision
making in chronic disease management is often com-
plicated and that it is not always possible for a com-
puter program to cover this process completely.29
Perceived support and the GPs’
comments
There was a wide range in the individual values for the
perceived support on the VAS-scale (from 0 to 81 mm),
implying that the perceived support was dependent
on the speciﬁc case, rather than on the CDSS itself.
Generally, the values were more often within the higher
range when the GPs reported improved conﬁdence,
when they considered further investigations and when
they made an assenting comment. That could imply
that when the CDSS provided conﬁrmation or ideas
that were new to them, the GPs appreciated this. We
have found only a few studies assessing what kind of
feedback from a CDSS increases user satisfaction and
it seems that users appreciate patient-speciﬁc advice
more than only general textual information,30 and
especially when assessingmore complicated cases with
several concomitant diseases and medications.31 In our
study the users seemed to react most positively when
they felt that the CDSS was ﬁlling in gaps and stimu-
lating further reasoning. Whether those cases were
more complicated than the others cannot be assessed
in our study as we do not have detailed patient data
related to conditions other than CHF. We know from
theGPs’ comments, however, that certain circumstances
in the clinical situation could also be perceived as
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limiting the usability of the CDSS (such as very old
age or the presence of other severe conditions). We
probably would have seen a stronger inﬂuence of the
CDSS if we had restricted the evaluation to caseswhere
the GPs themselves felt a need to use it. However, with
such a design the data collection would have taken an
unacceptably long time. For optimal eﬀect in everyday
clinical work, we believe it is advantageous to let the
GP decide for themselves when to use the program. The
fact that the CDSS did not allow a two-drug combi-
nation that was regularly used at this clinic turned out
to be a drawback, according to the GPs’ comments.
The CHF cases
Age and gender distributions of the patients as well
as the prevalence of the related conditions and the
proportion of patients who underwent echocardi-
ography were similar to those reported for Sweden
in a large international survey on the management of
CHF in primary care.32 The total usage of ACE inhib-
itors or angiotensin II receptor antagonists was also on
the same level, but the usage of diuretics and
betablockers was somewhat higher in our study.
Strengths
The main strength of this study is that the CDSS was
tested on real-life patients by the GPs who were taking
care of them – imitating real clinical situations. Each
patient case was familiar to the GP who made the
assessment with the support of the CDSS, thus con-
stituting a revision of the GP’s previous judgement of
the case.
The program itself was an advanced CDSS, not only
translating clinical guidelines to patient-speciﬁc ad-
vice, but also providing descriptions of the rules in the
guidelines and explanations for the suggestions, which
has been shown to increase user acceptance.33 It also
possessed three of the four most important features
identiﬁed by a meta-analysis as being associated with
improved clinical practice: provision of decision sup-
port at the time and location of decision making,
provision of a recommendation rather than just an
assessment and computer-based generation of deci-
sion support.34
Limitations
One limitation of the study is that we had a small
sample of GPs, thereby restricting the possibilities for
generalisation of the results. As we did not have any
control group, we cannot with certainty diﬀerentiate
the eﬀect of theCDSS from the eﬀect of theGPs simply
reasoning about the management of their CHF cases a
second time. It would also have been advantageous
to have further data about the patients’ medical back-
ground, such as duration of the CHF and other
comorbidities, in order to better illuminate the de-
cision-making situation of the GPs. However, it was
not possible to ﬁnd reliable data regarding those factors.
The only data we have are the NYHA classiﬁcation of
function, which gives a picture of the severity of the
CHF, and some medical conditions of importance
regarding the selection of medications (see Table 2).
Another limitation is that the cases already had a
previously stated diagnosis and ongoing treatment.
The diagnostic module was most useful when used in
new cases and when the diagnostic investigations for
CHF had been performed recently. When the investi-
gations had been done further in the past or the
patients were already using treatment for CHF,
thereby diminishing the symptoms and signs, the
program could have underestimated the presence of
CHF. Patients with CHF were selected by searching
the EPR, and this could also limit the possibility of
attaining themaximal eﬀect of theCDSS: other studies
have shown that ﬁnding patients with CHF by search-
ing the problem list of the EPR is most often not
suﬃciently reliable.35 Inclusion of the cases where the
GP did not think of the possibility of CHF or felt too
uncertain to record the diagnosis could have improved
our results, as the CDSS could probably give most
support in those cases.
Conclusions
The present CDSS inﬂuenced the GPs’ conﬁdence in
the diagnosis of CHF in every fourth case, their
considerations about investigations in every third
case and their considerations about medications in
almost every ﬁfth case. The perceived support from
the use of the CDSS reported by the GPs could be
described as substantial in one-third of the cases.
Therefore, applying a CDSS based on evidence-based
guidelines to themedical records of patients with CHF
in primary care could have a signiﬁcant inﬂuence on
GPs’ disease management.
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